公司资料
Sonoma Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- SNOA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.34 USD (0.00%)
收盘价
最后更新: 2026年8月21日
4.03M USD
市值
股价为何变动
As of Aug 21, 2026, SNOA was little changed and closed at $1.34. No new same-company headline was identified in the current news window.
公司概览
Hypochlorous Acid Medical Products
Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid products for wound care, eye care, nasal care, oral care, dermatology, podiatry, animal health, and non-toxic disinfection.
Microcyn Technology
The company’s Microcyn technology produces safe and stable HOCl formulations. The products are intended to reduce itching, pain, scarring, and irritation without damaging healthy tissue and are used in applications including minor abrasions, cuts, and intact-skin management.
Broad End-Market Portfolio
Sonoma adapts the same stabilized HOCl technology across human and animal healthcare. This creates a product portfolio serving wound care, dermatology, eye and nasal care, oral care, podiatry, animal health, and non-toxic disinfection.
Global Commercial Network
Sonoma products are sold directly or through partners in more than 55 countries. The company has recently expanded its U.S. product lineup and channel relationships, including the manufacture of a new HOCl wound cleanser for Medline.
未来催化剂
- Sonoma’s catalysts are wound-care and skin-health product demand, along with any update that clarifies the commercial path. The business moves on product adoption.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。